Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow AVITA Medical, Inc.

Get SEC filing alerts via email and in your feed for AVITA Medical, Inc.

RCEL AVHHL

AVITA Medical, Inc.

About AVITA Medical, Inc.

AVITA Medical develops and commercializes advanced acute wound care solutions centered on its patented RECELL technology, which creates autologous skin cell suspensions to accelerate healing of burns, full-thickness skin defects, and vitiligo. The company’s product portfolio includes RECELL devices and complementary wound care matrices like PermeaDerm and Cohealyx. Serving burn and trauma centers primarily in the U.S. and select international markets, AVITA leverages proprietary technology, regulatory approvals, and clinical evidence to improve patient outcomes and reduce treatment costs.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from AVITA Medical, Inc.

1
1
AVITA Medical, Inc. AVITA Medical Reports $19.3 Million Revenue and $10.6 Million Net Loss for Q1 2026

Via official filing (AI summary) | 21 days ago | 0 comments

2
1
AVITA Medical, Inc. AVITA Medical Reports $71.6 Million Revenue for Fiscal Year 2025, Net Loss Reduces to $48.6 Million

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
AVITA Medical, Inc. AVITA Medical Reports Q3 2025 Revenue Decline to $17.1 Million Amid Reimbursement Challenges

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
AVITA Medical, Inc. AVITA Medical Reports 21% Revenue Growth to $18.4 Million in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
AVITA Medical, Inc. AVITA Medical Reports 67% Revenue Growth to $18.5 Million, Net Loss Improves

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
AVITA Medical, Inc. AVITA Medical Reports 28% Revenue Growth to $64.3 Million, Despite Increased Net Loss

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
AVITA Medical, Inc. AVITA Medical Reports 43.2% Revenue Growth, Widened Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments